And she got her hair back
In summary, GLP-1R on -cells is activated and promotes growth inhibitory hormone secretion, creating a multilayered inhibitory mechanism that effectively reduces glucagon secretion, and in turn lowers blood glucose levels
Interesting data, highlighting potential deficits in real world applicability of RCT around weight loss medications
Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders
[DOI] [PubMed] [Google Scholar] 22.Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans
Metabolic Daily PRO: The Broader Daily Ecosystem Formula Metabolic Daily PRO uses a broader five-strain approach: Akkermansia muciniphila Clostridium butyricum Anaerobutyricum hallii Clostridium beijerinckii Bifidobacterium infantis These organisms were selected for complementary roles involving mucin metabolism, carbohydrate fermentation, cross-feeding and production of short-chain fatty acids such as butyrate
